Department of Pharmacology, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California, San Diego , La Jolla, California 92093-0650, United States.
Facultad de Ciencias Químicas e Ingeniería, Universidad Autónoma de Baja California , Calzada Universidad 14418, Tijuana, Baja California 22390, Mexico.
J Am Chem Soc. 2017 Mar 15;139(10):3676-3684. doi: 10.1021/jacs.6b10746. Epub 2017 Mar 1.
Through studies with ligand binding to the acetylcholine binding protein (AChBP), we previously identified a series of 4,6-substituted 2-aminopyrimidines that associate with this soluble surrogate of the nicotinic acetylcholine receptor (nAChR) in a cooperative fashion, not seen for classical nicotinic agonists and antagonists. To examine receptor interactions of this structural family on ligand-gated ion channels, we employed HEK cells transfected with cDNAs encoding three requisite receptor subtypes: α7-nAChR, α4β2-nAChR, and a serotonin receptor (5-HTR), along with a fluorescent reporter. Initial screening of a series of over 50 newly characterized 2-aminopyrimidines with affinity for AChBP showed only two to be agonists on the α7-nAChR below 10 μM concentration. Their unique structural features were incorporated into design of a second subset of 2-aminopyrimidines yielding several congeners that elicited α7 activation with EC values of 70 nM and K values for AChBP in a similar range. Several compounds within this series exhibit specificity for the α7-nAChR, showing no activation or antagonism of α4β2-nAChR or 5-HT3AR at concentrations up to 10 μM, while others were weaker antagonists (or partial agonists) on these receptors. Analysis following cocrystallization of four ligand complexes with AChBP show binding at the subunit interface, but with an orientation or binding pose that differs from classical nicotinic agonists and antagonists and from the previously analyzed set of 2-aminopyrimidines that displayed distinct cooperative interactions with AChBP. Orientations of aromatic side chains of these complexes are distinctive, suggesting new modes of binding at the agonist-antagonist site and perhaps an allosteric action for heteromeric nAChRs.
通过与乙酰胆碱结合蛋白 (AChBP) 的配体结合研究,我们之前确定了一系列 4,6-取代的 2-氨基嘧啶,它们以协同方式与这种可溶性烟碱型乙酰胆碱受体 (nAChR) 的替代物结合,而不是经典的烟碱激动剂和拮抗剂。为了研究这个结构家族在配体门控离子通道上的受体相互作用,我们使用转染了编码三种必需受体亚型(α7-nAChR、α4β2-nAChR 和 5-羟色胺受体 (5-HTR) 的 cDNA 的 HEK 细胞,以及一个荧光报告基因。对一系列超过 50 种新表征的与 AChBP 具有亲和力的 2-氨基嘧啶进行初步筛选,结果仅发现两种在低于 10 μM 浓度下对 α7-nAChR 具有激动作用。它们独特的结构特征被纳入了第二个 2-氨基嘧啶亚类的设计中,产生了几个具有类似 EC 值的同类物,可引发 α7 激活,而 AChBP 的 K 值也在相似范围内。该系列中的几种化合物对 α7-nAChR 具有特异性,在高达 10 μM 的浓度下对 α4β2-nAChR 或 5-HT3AR 没有激活或拮抗作用,而其他化合物在这些受体上则较弱的拮抗剂(或部分激动剂)。在与 AChBP 共结晶的四个配体复合物的分析表明,结合发生在亚基界面,但结合的方向或结合构象与经典的烟碱激动剂和拮抗剂以及之前分析的具有与 AChBP 明显协同相互作用的一组 2-氨基嘧啶不同。这些复合物的芳香侧链的取向是独特的,这表明在激动剂-拮抗剂结合位点存在新的结合模式,并且可能对异源 nAChR 具有变构作用。